Yahoo Web Search

  1. Yahoo Finance Results

  2. NASDAQ: GHDX) Haemonetics Corporation (NYSE: HAE) Inspire Medical Systems Inc (NYSE: INSP) Masimo Corporation (NASDAQ: MASI) Myriad Genetics, Inc. NASDAQ: MYGN) Neurocrine Biosciences, Inc.

  3. Novartis to Sell Parts of Sandoz for $1 Billion: Novartis said it will sell selected portions of the Sandoz US portfolio, comprising approximately 300 products, to Aurobindo Pharma USA Inc., ...

    92.05-2.93 (-3.08%)

    at Fri, Sep 21, 2018, 14:53PM EST - U.S. Markets open in 1 hr 15 mins

    Pre Mkt N/A

    • Ask Price 0.00
    • Bid Price 0.00
    • P/E 53.46
    • 52 Wk. High 101.47
    • 52 Wk. Low 0.00
    • Mkt. Cap 26.61B
  4. Chicago, IL –September 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting ...

  5. Web results

  6. About Eisai | Eisai Co., Ltd.

    www.eisai.com/company/index.htmlCached

    Welcome to the Eisai Official Corporate Website About Eisai Page.

  7. Stock analysis for Eisai Co Ltd (4523:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  8. ESALF Stock Price - Eisai Co. Ltd. Stock Quote (U.S.: OTC ...

    www.marketwatch.com/investing/stock/esalf

    Eisai Co. Ltd. stock price, stock quotes and financial overviews from MarketWatch.

  9. ESALF Key Statistics - Eisai Co. Ltd. Financial Ratios ...

    www.marketwatch.com/investing/stock/esalf/profile

    Updated key statistics for Eisai Co. Ltd. - including esalf margins, P/E ratio, valuation, profitability, company description, and other stock analysis data.

  10. Eisai (company) - Wikipedia

    en.wikipedia.org/wiki/Eisai_(company)Cached

    Nihon Eisai Co. Ltd. was established in 1941. In 1944, merger with Sakuragaoka Research Laboratory resulted in creation of Eisai Co. Ltd. [3] The American subsidiary of the company, Eisai Inc., was established in 1995.

  11. Eisai Co., Ltd. ADR 2018 Q1 - Results - Earnings Call Slides ...

    seekingalpha.com/article/4193222-eisai-co-ltd...

    The following slide deck was published by Eisai Co., Ltd. ADR in conjunction with their 2018 Q1 earnings call.

  12. Eisai Co Ltd, 4523:TYO summary - FT.com

    markets.ft.com/data/equities/tearsheet/summary?s=...Cached

    Latest Eisai Co Ltd (4523:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  13. Welcome to Eisai Inc. Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

  14. Eisai Co., Ltd. and Merck Enter Global Strategic Oncology ...

    investors.merck.com/news/press-release-details/2018/...Cached

    Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as “giving ...

  1. Ad
    related to EISAI, Co., Ltd